AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

AstraZeneca is an innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines that are innovative, effective, and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focuses on getting the best from every medicine they make by exploring all the ways it can be used or improved. AstraZeneca was established on April 6, 1999, in Cambridgeshire, United Kingdom.

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Nippon Chemiphar Co., Ltd. engages in the healthcare business. It manufactures, sells, imports, and exports ethical pharmaceuticals and diagnostic agents. It operates through the Pharmaceuticals and Others segments. The Pharmaceuticals segment manufactures and sells prescription drugs. The Others segment includes safety testing consignment, healthcare, and real estate businesses. The company was founded by Akira Yamaguchi on June 16, 1950 and is headquartered in Tokyo, Japan.

Boehringer Ingelheim KG, part of C.H. Boehringer Sohn AG & Co. KG, is a company headquartered in Biberach, Germany. The firm wholesales pharmaceutical products. It was founded in 1981.

Huls, part of Oranjewoud NV, is a company headquartered in the Netherlands that provides building, maintenance and renovation services. It was acquired by Strukton Bouw & Onderhoud on December 01, 1999.\nThe company says this about itself: HULS is a creative company based in Tokyo and Singapore. Through global website productions, products planning or providing resources and information, we support and help in the overseas expansion of Japanese businesses. We are always on the look out for potential Japanese products/materials manufacturers/ industries for overseas expansion. We are focused on the development of the creative industries in Asia while being centered around Singapore. Under the concept of \"Roots & Touch\", we aim to establish a platform that will bridge across international borders strategically by connecting different cultures and businesses together.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Hikal Ltd. engages in the manufacture of chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. It operates through the Crop Protection and Pharmaceuticals segments. The Crop Protection segment involves in manufacturing of intermediates and active ingredients. The Pharmaceuticals segment offers contract development and manufacturing; APIs and intermediates; animal health, and project management. The company was founded by Jai Hiremath on July 8, 1988 and is headquartered in Mumbai, India.

Produces solid propellant rocket motors

Imperial Chemical Industries (ICI) was a British chemical company and was, for much of its history, the largest manufacturer in Britain. It was formed by the merger of leading British chemical companies in 1926. Its headquarters were at Millbank in London, and it was a constituent of the FT 30 and later the FTSE 100 indices.

Boehringer Ingelheim Ltd. develops, manufactures, and distributes pharmaceutical products. It offers products for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, Parkinson's disease, arthritis, and pain relief in cancer. The company was founded in 1885 and is headquartered in Bracknell, the United Kingdom.

Numedicus’ approach to new products is based on therapeutic switches, namely new uses for known drugs, and alternatively called ‘drug reprofiling’, ‘drug repositioning’ or ‘drug repurposing’.Therapeutic switch projects are attractive because they can be commercialised more quickly, and with lower risk than medicines resulting from traditional approaches; they may also be underpinned by patents. Not only is there a greater chance of development succeeding but the R&D costs are a fraction of that incurred with a new chemical entity.

Zeneca is a British multinational pharmaceutical company focused on therapeutic oncology and cardiovascular products. Zeneca was established in June 1993 through a demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries. In 1999 Zeneca and Astra AB, a Sweden-based pharmaceutical company, merged to form AstraZeneca plc.

Hanseo Chemical Co., Ltd. is a South Korean private company that manufactures turbines.